Givaudan | GIVN - Market Capitalization


Givaudan reported CHF26.45B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 92.72B 8.6B Dec/2025
Akzo Nobel EUR 8.42B 1.71B Mar/2026
Anheuser-Busch USD 139.3B 9.1B Mar/2026
Arkema EUR 4.43B 467.77M Mar/2026
BASF EUR 46.77B 7.11B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
British American Tobacco GBP 91.84B 15.8B Dec/2025
Covestro EUR 12.54B 1.53B Dec/2025
Croda International GBP 3.76B 319.76M Dec/2025
Danone EUR 52.32B 5.06B Dec/2025
Diageo GBP 48.1B 7.77B Dec/2025
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Givaudan CHF 29.05B 6.42B Dec/2025
Glanbia EUR 4.14B 3.32B Jun/2026
Heineken EUR 40.17B 2.47B Dec/2025
Henkel EUR 29.28B 1.43B Dec/2025
International Flavors Fragrances USD 18.53B 1.27B Mar/2026
Kerry EUR 15.52B 2.48B Dec/2024
Lonza CHF 39.68B 980.61M Jun/2025
L'Oréal EUR 195.68B 1.67B Dec/2025
Merck EUR 46.78B 6.52B Mar/2026
Nestle CHF 202.88B 231.89M Dec/2025
Pernod Ricard EUR 18.44B 2.9B Dec/2025
Reckitt Benckiser GBP 38.8B 5.14B Dec/2025
SGS CHF 17.22B 1.83B Dec/2024
Sika AG CHF 26.09B 8.47B Dec/2025
Solvay EUR 2.8B 74.11M Mar/2026
Umicore EUR 4.41B 1.34B Dec/2025